| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/23/2005 | WO2005056777A1 Adhesive stem cell fraction, method of separating the same, quality management method and quality management apparatus |
| 06/23/2005 | WO2005056771A2 In vitro uptake of spam 1 (ph-20) by mammalian sperm |
| 06/23/2005 | WO2005056765A2 Methods for culturing keratinocytes from human embryonic stem cells |
| 06/23/2005 | WO2005056761A2 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 06/23/2005 | WO2005056755A2 Compositions and methods for propagation of neural progenitor cells |
| 06/23/2005 | WO2005056751A2 Apparatus and method for concentrating stem cell |
| 06/23/2005 | WO2005056608A1 Modified macromolecules and methods of making and using thereof |
| 06/23/2005 | WO2005056569A2 Beta integrin gene and protein |
| 06/23/2005 | WO2005056072A1 Method of constructing three-dimensional cartilage tissue by using myeloid cells in pseudo-microgravity environment |
| 06/23/2005 | WO2005056039A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/23/2005 | WO2005055979A2 Ph triggerable polymeric particles or films containing a poly (beta-amino ester) |
| 06/23/2005 | WO2005055936A2 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 06/23/2005 | WO2005055877A2 Method for the production of intervertebral disk tissue from degenerate intervertebral disk tissue |
| 06/23/2005 | WO2005047494A3 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 06/23/2005 | WO2005044972A3 A three-dimensional carrier for culturing microbiological material |
| 06/23/2005 | WO2005037996A3 In vitro development of tissues and organs |
| 06/23/2005 | WO2005037863A9 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 06/23/2005 | WO2005019270A3 Endotheliase-2 ligands |
| 06/23/2005 | WO2005017130A3 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof |
| 06/23/2005 | WO2005007808A3 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 06/23/2005 | WO2005005608A3 Compositions and methods for differentiating adipose stromal cells into pancratic beta cells |
| 06/23/2005 | WO2005000901A3 Cd20-specific antibodies and methods of employing same |
| 06/23/2005 | WO2005000376A3 Bio-artificial liver system |
| 06/23/2005 | WO2004078928A3 T cell regulation |
| 06/23/2005 | WO2004052184A3 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/23/2005 | WO2004003151A3 Protein production methods and modified cells for use therein |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | US20050138695 Transgene confers herbicide resistance to glyphosate, sulfonylurea, imidazolinone, glufosinate, phenoxy proprionic acid, cycloshexone, triazine, and/ or benzonitrile; genetic engineering |
| 06/23/2005 | US20050138690 Expression vector comprising exogenous regulatory and gene sequences for use in generation of plants with tissue specific expression of heterologous gene product; improving exogenous gene expression |
| 06/23/2005 | US20050138689 Expression vector coding short interfering RNA sequences for use as tool in controlling gene expression in plants; gene expression inhibition; target sequence suppression and target sequence validation |
| 06/23/2005 | US20050138687 Using viral cell-to-cell transfer as screening and diagnostic tool in identifying triple gene block 3 mutants; generating disease resistant plants |
| 06/23/2005 | US20050138686 Alternative splicing factors polynucleotides polypeptides and uses thereof |
| 06/23/2005 | US20050137385 IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses |
| 06/23/2005 | US20050137112 determining lymphocyte epitopes in proteins comprising obtaining from blood, a solution of dendritic cells and CD4 antigens, then promoting cell differentiation, by exposing to cytokines, then mixing with peptides of interest and measuring the proliferation of lymphocytes |
| 06/23/2005 | US20050136539 Generating immortalized human renal proximal tubule epithelial cell (RPTEC) for use as model for identifying modulators of renal toxicity |
| 06/23/2005 | US20050136538 Comprises epoxide substrate surface coated with photosenstive layer; photomask stencil is used to deposit electromagnetic radiation into coating in predetermined locations forming desired pattern |
| 06/23/2005 | US20050136536 Which express cytokeratin, on copolymerized 1,4-butanediol dimethacrylate, diethylene glycol dimethacrylate cell support; cultured in retinoic acid |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136511 GABA B receptors |
| 06/23/2005 | US20050136494 Expression vector comprising nucleotide sequences coding immunoglobulin specific to transmembrane receptor for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136467 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 06/23/2005 | US20050136429 SIRT1 modulation of adipogenesis and adipose function |
| 06/23/2005 | US20050136409 comprising biopolymer-coated erythrocytes simulating a component of blood samples, obtained by binding biopolymers to the external surface of cells, the biopolymers comprising nucleic acids, peptide nucleic acids, or mucopolysaccharides; used in cytometer or analysis apparatus |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136391 Cooling storage; sterilization solution; mixture of potassium sulfate, aspartic acid, magnesium sulfate, calcium sulfate, potassium phosphate, ethylenediaminetetraacetic acid, taurine, zinc sulfate |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | US20050136054 Humanised antibodies |
| 06/23/2005 | US20050136042 Methods and compositions for tissue repair |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | US20050136040 Peptide nucleic acid of a nucleic acid binding portion and a repressor portion of a polypeptide or peptidomimetic; drug design; gene expression inhibition |
| 06/23/2005 | US20050136039 Can exhibit decreased expression of: fatty acid synthase (FAS), adipogenic transcription factors SREBP-1c or C/EBP alpha , beta 3 adrenergic receptor, and fatty acid transport protein 1 (FATP1); use drug screening; prognosis of obesity; diabetes; reduction of insulin receptor signaling |
| 06/23/2005 | US20050136035 Targeted adenovirus vectors include co-transcribed genes under transcriptional control of the same heterologous transcriptional regulatory element (TRE), wherein a second gene is under translational control of a self processing cleavage sequence or 2A sequence; cell or tissue-targeted therapy; e.g. tumor |
| 06/23/2005 | DE20023640U1 Detecting an embryonic cell surface marker e.g. cartilage-derived morphogenic protein CDMP-1 so as to positively identify viable precursor cells that have entered a post-natal differentiation pathway |
| 06/23/2005 | DE10354403A1 Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung Against the prothrombin fragment 1 + F 2 directed antibody, their preparation and use |
| 06/23/2005 | DE102004055686A1 New modified sarcosine oxidase, useful as diagnostic reagent for measuring creatinine or creatine, has reduced activity on N-ethylglycine, also nucleic acid that encodes it |
| 06/23/2005 | DE10162814B4 Rekonstruiertes Haarfollikelmodell Reconstructed hair follicle |
| 06/23/2005 | CA2549384A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 06/23/2005 | CA2549295A1 Modified macromolecules and methods of making and using thereof |
| 06/23/2005 | CA2549164A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/23/2005 | CA2548929A1 Cell death inducing agent |
| 06/23/2005 | CA2548567A1 Anti-mpl antibody |
| 06/23/2005 | CA2548310A1 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 06/23/2005 | CA2548180A1 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 06/23/2005 | CA2548157A1 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23. |
| 06/23/2005 | CA2548015A1 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 06/23/2005 | CA2547827A1 Compositions and methods for propagation of neural progenitor cells |
| 06/23/2005 | CA2546465A1 Identification, isolation and elimination of cancer stem cells |
| 06/22/2005 | EP1544303A2 Modification of plant metabolism |
| 06/22/2005 | EP1544301A1 DNA molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544292A1 Glucose dehydrogenase |
| 06/22/2005 | EP1544290A1 A cell system for generating somatic cells |
| 06/22/2005 | EP1544289A1 Method of generating neurons from stem cells and medium for culturing stem cells |
| 06/22/2005 | EP1543329A2 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543128A2 Viral vectors containing recombination sites |
| 06/22/2005 | EP1543114A2 Aldehyde dehydrogenase gene |
| 06/22/2005 | EP1543112A1 Regulating beta-catenin levels |
| 06/22/2005 | EP1543111A2 Neurogenesis from hepatic stem cells |
| 06/22/2005 | EP1543110A2 Mesoderm and definitive endoderm cell populations |
| 06/22/2005 | EP1543109A2 Substances for preventing and treating autoimmune diseases |
| 06/22/2005 | EP1543107A1 A method of and apparatus for facilitating processes of mammalian cells |
| 06/22/2005 | EP1543106A2 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 06/22/2005 | EP1543026A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 06/22/2005 | EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1542998A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 06/22/2005 | EP1542737A2 Fibrin cell supports and methods of use thereof |
| 06/22/2005 | EP1542721A1 Modified "s" antibodies |
| 06/22/2005 | EP1542714A1 Methods of increasing platelet and hematopoietic stem cell production |
| 06/22/2005 | EP1542713A2 Skrp, astray, string, vacm associated with metabolic control |
| 06/22/2005 | EP1542710A1 Methods for preserving organs and tissues |
| 06/22/2005 | EP1542707A2 Compositions and methods for ligament growth and repair |
| 06/22/2005 | EP1542536A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 06/22/2005 | EP1542532A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 06/22/2005 | EP1542529A2 Sperm cell process system |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |